8-90645778-G-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001008495.4(TMEM64):c.128C>A(p.Ala43Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000509 in 1,020,622 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001008495.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TMEM64 | NM_001008495.4 | c.128C>A | p.Ala43Glu | missense_variant | 1/3 | ENST00000458549.7 | NP_001008495.2 | |
TMEM64 | NM_001146273.1 | c.128C>A | p.Ala43Glu | missense_variant | 1/2 | NP_001139745.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TMEM64 | ENST00000458549.7 | c.128C>A | p.Ala43Glu | missense_variant | 1/3 | 1 | NM_001008495.4 | ENSP00000414786 | P1 | |
LINC00534 | ENST00000667296.1 | n.457-23262G>T | intron_variant, non_coding_transcript_variant |
Frequencies
GnomAD3 genomes AF: 0.0000204 AC: 3AN: 147160Hom.: 0 Cov.: 32
GnomAD4 exome AF: 0.0000561 AC: 49AN: 873462Hom.: 0 Cov.: 30 AF XY: 0.0000663 AC XY: 27AN XY: 407244
GnomAD4 genome AF: 0.0000204 AC: 3AN: 147160Hom.: 0 Cov.: 32 AF XY: 0.0000140 AC XY: 1AN XY: 71600
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 30, 2023 | The c.128C>A (p.A43E) alteration is located in exon 1 (coding exon 1) of the TMEM64 gene. This alteration results from a C to A substitution at nucleotide position 128, causing the alanine (A) at amino acid position 43 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at